Protein structure characterization with mass spectrometry

Spectroscopy

Volumn 18, Issue 1, 2004, Pages 37-47

  Kriwacki, Richard ^a   Reisdorph, Nichole ^b   Siuzdak, Gary ^b  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL MODIFICATION; CONFORMATIONS; MASS SPECTROMETRY; VIRUSES;

MASS ANALYSIS TECHNIQUES; PROTEOLYTIC DIGESTION;

PROTEINS;

PROTEINASE; VIRUS PROTEIN;

ACCURACY; CHEMICAL MODIFICATION; CROSS LINKING; HUMAN RHINOVIRUS; MASS SPECTROMETRY; MOLECULAR PROBE; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN STRUCTURE; REVIEW; VIRUS CAPSID;

EID: 1242329225     PISSN: 07124813     EISSN: None     Source Type: Journal    
DOI: 10.1155/2004/407960     Document Type: Review

References (33)

1. A.P. Jonsson, Mass spectrometry for protein and peptide characterisation, Cell. Mol. Life Sci. 58 (2001), 868-884.
2. T.J. Griffin and R. Aebersold, Advances in proteome analysis by mass spectrometry, JBC 276 (2001), 45497-45500.
3. R.W. Kriwacki, J. Wu, G. Siuzdak and P.E. Wright, Probing protein/ protein interactions with mass spectromety and isotopic labeling: analysis of the p21/Cdk2 complex, J. Amer. Chem. Soc. 118 (1996), 5320.
4. R.W. Kriwacki, J. Wu, T. Tennant, P.E. Wright and G. Siuzdak, Probing protein structure using biochemical and biophysical methods. Proteolysis, matrix-assisted laser desorption/ionization mass spectrometry, high-performance liquid chromatography and size-exclusion chromatography of p21Waf1/Cip1/Sdi1, Journal of Chromatography 777 (1997), 23-30.
5. J.K. Lewis, B. Bothner, T.J. Smith and G. Siuzdak, Antiviral agent blocks breathing of the common cold virus, PNAS 95 (1998), 6774-6778.
6. S.L. Cohen, A.R. Ferre-D'Amare, S.K. Burley and B.T. Chait, Probing the solution structure of the DNA-binding protein Max by a combination of proteolysis and mass spectrometry, Protein Science 4 (1995), 1088-1099.
7. A. Fontana et al., Probing the conformational state of apomyoglobin by limited proteolysis, J. Mol. Biol. 266(2) (1997), 223-230.
8. A. Fontana, P.P. de Laureto, V. De Filippis, E. Scaramella and M. Zambonin, Probing the partly folded states of proteins by limited proteolysis, Folding and Design 2 (1997), R17-26.
9. J.J. Chou, S. Li, C.B. Klee and A. Bax, Solution structure of Ca(2+)-calmodulin reveals flexible hand-like properties of its domains, Nat. Struct. Biol. 8(11) (2001), 990-997.
10. B.E. Finn, J. Evenas, T. Drakenberg, J.P. Waltho, E. Thulin and S. Forsen, Calcium-induced structural changes and domain autonomy in calmodulin, Nat. Struct. Biol. 2(9) (1995), 777-783.
11. J.K. Lewis, Protein structural characterization using bioreactive mass spectrometer probes, Ph.D. Thesis Dissertation, Arizona State University, 1997.
12. R.L. Winston and M.C. Fitzgerald, Mass spectrometry as a readout of protein structure and function, Mass Spectrom. Rev. 16(4) (1997), 165-179.
13. T.W. Muir, M.J. Williams and S.B. Kent, Detection of synthetic protein isomers and conformers by electrospray mass spectrometry, Anal. Biochem. 224(1) (1995), 100-109.
14. L. Wang, H. Pan and D.L. Smith, Hydrogen exchange-mass spectrometry: optimization of digestion conditions, Mol. Cell. Proteomics 1(2) (2002), 132-138.
15. A. Miranker, C.V. Robinson, S.E. Radford, R.T. Aplin and C.M. Dobson, Detection of transient protein folding populations by mass spectrometry, Science 262 (1993), 896-900.
16. R.W. Kriwacki, L. Hengst, L. Tennant, S.I. Reed, P.E. Wright, Structural studies of p21Waf1/Cip1/Sdi1 in the free and Cdk2-bound state: Conformational disorder mediates binding diversity, Proc. Natl. Acad. Sci. USA 93 (1996), 11504-11509.
17. J.W. Harper, G.R. Adami, N. Wei, K. Keyomarsi and S.J. Elledge, The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases, Cell 75 (1993), 805.
18. W.S. el-Deiry, T. Tokino, V.E. Velculescu, D.B. Levy, R. Parsons, J.M. Trent, D. Lin, W.E. Mercer, K.W. Kinzler and B. Vogelstein, WAF1, a potential mediator of p53 tumor suppression, Cell 75 (1993), 817-825.
19. H. Toyoshima and T. Hunter, p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21, Cell 78 (1994), 67-74.
20. K. Polyak, M. Lee, H. Erdjument-Bromage, A. Koff, J.M. Roberts, P. Tempst and J. Massagué, Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals, Cell 78 (1994), 59-66.
21. M.-H. Lee, I. Reynisdottir and J. Massagué, Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution, Genes Dev. 9 (1995), 639-649.
22. S. Matsuoka, M.C. Edwards, C. Bai, S. Parker, P.B. Zhang, A. Baldini, J.W. Harper and S.J. Elledge, p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene, Genes Dev. 9 (1995), 650-662.
23. M. Nakanishi, R.S. Robetorye, G.R. Adami, O.M. Pereira-Smith and J.R. Smith, Identification of the active region of the DNA synthesis inhibitory gene p21Sdi1/CIP1/WAF1, EMBO J. 14 (1995), 555-563.
24. J. Chen, P.K. Jackson, M.W. Kirschner and A. Dutta, Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA, Nature 374 (1995), 386-388.
25. Y. Luo, J. Hurwitz and J. Massagué, Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1, Nature 375 (1995), 159-161.
26. A.A. Russo, P.D. Jeffrey, A.K. Patten, J. Massague and J.N.P. Pavletich, Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor bound to the cyclin A-Cdk2 complex, Nature 382 (1996), 325-331.
27. B. Bothner, X.-F. Dong, L. Bibbs, J.E. Johnson and G. Siuzdak, Evidence of viral capsid dynamics using limited proteolysis and mass spectrometry, J. Biol. Chem. 273 (1998), 673-676.
28. Y. Ho, A. Gruhler, A. Heilbut, G.D. Bader, L. Moore, S.L. Adams, A. Millar, P. Taylor, K. Bennett, K. Boutilier, L. Yang, C. Wolting, I. Donaldson, S. Schandorff, J. Shewnarane, M. Vo, J. Taggart, M. Goudreault, B. Muskat, C. Alfarano, D. Dewar, Z. Lin, K. Michalickova, A.R. Willems, H. Sassi, P.A. Nielsen, K.I. Rasmussen, J.R. Andersen, L.E. Johansen, L.H. Hansen, H. Jespersen, A. Podtelejnikov, E. Nielsen, J. Crawford, V. Poulsen, B.D. Sorensen, J. Matthiesen, R.C. Hendrickson, F. Gleeson, T. Pawson, M.F. Moran, D. Durocher, M. Mann, C.W. Hogue, D. Figeys and M. Tyers, Systematic identification of protein complexes in Saccharomyces cerevisiae by mass spectrometry, Nature 415 (2002), 180-183.
29. G. Siuzdak, B. Bothner, M. Yeager, C. Brugidou, C.M. Fauquet, K. Hoey and C.-M. Chang, Mass spectrometry and viral analysis, Chemistry and Biology 3 (1996), 45-48.
30. G. Siuzdak, Probing viruses with mass spectrometry, J. Mass Spectrom. 33(3) (1998), 203-211.
31. K.M. Broo, J. Wei, D. Marshall, F. Brown, T.J. Smith, J.E. Johnson, A. Schneemann and G. Siuzdak, Viral capsid mobility: a dynamic conduit for inactivation, PNAS 98 (2001), 2274-2277.
32. M.O. Glocker, C. Borchers, W. Fiedler, D. Suckau and M. Przybylski, Molecular characterization of surface topology in protein tertiary structures by amino-acylation and mass spectrometric peptide mapping, Bioconjug. Chem. 5 (1994), 583-590.
33. L. Florens, M.P. Washburn, J.D. Raine, R.M. Anthony, M. Grainger, J.D. Hayness, J.K. Moch, N. Muster, J.B. Sacci, D.L. Tabb, A.A. Witney, D. Wolters, Y. Wu, M.J. Gardner, A.A. Holder, R.E. Sinden, J.R. Yates and D.J. Carucci, A proteomic view of the Plasmodium falciparum life cycle, Nature 419 (2002), 520-526.